A 54-year-old woman is admitted to the intensive care unit for a severe exacerbation of chronic obstructive pulmonary disease. She is started on a continuous intravenous infusion of theophylline. After 48 hours, her plasma theophylline concentration reaches a steady state of . To aggressively optimize bronchodilation, the intensivist triples the infusion rate. Simultaneous with this rate increase, the patient is diagnosed with a suspected multidrug-resistant infection, and rifampin, a potent cytochrome P450 inducer, is added to her regimen. Pharmacokinetic analysis indicates that rifampin therapy will precisely double the hepatic clearance of theophylline without altering its volume of distribution.
If the new, tripled theophylline infusion rate is maintained, which of the following accurately describes the patient's new theophylline steady-state concentration and the time required to reach it (compared to the original time to reach steady state)?
- AThe steady-state concentration will decrease to , and the time required to reach it will be longer.
- BThe steady-state concentration will increase to , and the time required to reach it will be unchanged.
- The steady-state concentration will increase to , and the time required to reach it will be shorter.Cevap
- DThe steady-state concentration will increase to , and the time required to reach it will be shorter.
- EThe steady-state concentration will increase to , and the time required to reach it will be unchanged.